10-Q: Bath & Body Works Q1 2026 Earnings: Sales Dip, Profit Rises

Sentiment:

Quarterly Report


Bath & Body Works reported a 3.2% decrease in net sales for Q1 2026 compared to the prior year, but saw a significant increase in operating income driven by a one-time litigation settlement gain.

Summary

  • Net sales for the first quarter of 2026 were $1,378 million, a decrease of 3.2% ($46 million) compared to $1,424 million in the first quarter of 2025.
  • Operating income increased by 10.4% to $231 million in Q1 2026 from $209 million in Q1 2025, with the operating income rate improving to 16.8% from 14.7%.
  • The increase in operating income was primarily due to a $88 million pre-tax gain from settlements of payment card interchange fee litigation, which offset a decline in gross profit and net sales.
  • Gross profit decreased by $59 million to $587 million in Q1 2026, and the gross profit rate declined to 42.6% from 45.4% in Q1 2025.
  • General, Administrative, and Store Operating Expenses decreased by $81 million to $356 million, largely due to the litigation settlement gain.
  • The company repurchased $284 million principal amount of its outstanding 2027 Notes for $289 million in Q1 2026, resulting in an $8 million pre-tax loss.
  • Cash and cash equivalents decreased to $820 million as of May 2, 2026, from $953 million at the beginning of the year.
  • Capital expenditures were $49 million in Q1 2026, with the company expecting to invest approximately $270 million in capital expenditures for the full year 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed report; while sales declined, operating income saw a substantial increase due to a one-time gain, and the company is actively managing debt and investing in its transformation strategy.

Positives

  • Operating income increased by 10.4% to $231 million, driven by a significant litigation settlement gain.
  • Operating income rate improved to 16.8% from 14.7% in the prior year's quarter.
  • General, Administrative, and Store Operating Expenses decreased by $81 million, primarily due to the litigation settlement.
  • The company successfully repurchased and extinguished its remaining 2027 Notes, reducing debt.
  • The company has a strong liquidity position with $820 million in cash and cash equivalents and $544 million in availability under its ABL Facility.

Negatives

  • Net sales decreased by 3.2% to $1,378 million in Q1 2026 compared to Q1 2025.
  • Gross profit decreased by $59 million, and the gross profit rate declined to 42.6% from 45.4%.
  • Sales per average selling square foot decreased by 5.8% and sales per average store decreased by 5.7%.
  • The company incurred an $8 million pre-tax loss from the repurchase of its 2027 Notes.
  • Inventories increased to $782 million from $699 million at the start of the year, though down from $869 million in the prior year.

Risks

  • Macroeconomic factors, including the escalation of conflicts in the Middle East, have led to volatility in global energy markets, commodity pricing, transportation costs, and foreign currency exchange rates, increasing global economic uncertainty.
  • These macroeconomic events may affect consumer demand in certain markets and contribute to higher global inflation and input costs.
  • The company is subject to various claims and contingencies, including lawsuits, taxes, and regulatory matters, though management believes the ultimate liability will not have a material adverse effect.
  • The company's international business is subject to foreign currency exchange rate fluctuations.
  • The company's operations are seasonal, with the fourth quarter typically accounting for the highest net sales and profitability.

Future Outlook

The company expects the impact of its 'Consumer First Formula' transformation plan to build through the year and become more visible in financials as it moves through the remainder of 2026 and into 2027. The company anticipates investing approximately $270 million in capital expenditures for the full year 2026, focusing on high-return real estate, Consumer First Formula investments, and logistics and fulfillment upgrades.

Management Comments

  • The company launched the 'Consumer First Formula' in 2025, a multi-year transformation plan to revitalize Bath & Body Works across brand, product, and marketplace, aiming to attract new, younger consumers and unlock sustainable growth.
  • Early consumer response to the 'Consumer First Formula' is consistent with the roadmap, and the company expects its impact to build throughout the year.
  • The company believes its current cash position, cash flows from operations, and borrowing capacity under its ABL Facility will be sufficient to meet liquidity needs, including capital expenditure requirements, for at least the next twelve months.

Industry Context

StockSavvy.ai notes that Bath & Body Works' Q1 2026 results reflect a challenging retail environment characterized by declining sales but improved profitability due to cost management and one-time gains. The company's strategic transformation efforts, 'Consumer First Formula,' are aimed at adapting to evolving consumer preferences and driving future growth in the competitive personal care and home fragrance market.

Comparison to Industry Standards

  • The reported net sales decrease of 3.2% is a concern in the retail sector, where growth is often a key indicator of market share and consumer demand. Competitors like Ulta Beauty and Sephora have shown varying performance, with some segments of the beauty and personal care market demonstrating resilience.
  • The improvement in operating income margin, despite lower sales, highlights effective cost control measures, which is a positive trend observed across some retailers navigating inflationary pressures and supply chain challenges.
  • The company's focus on digital transformation and customer engagement through initiatives like the 'Consumer First Formula' aligns with broader industry trends towards omnichannel retail strategies and personalized customer experiences.

Legal Proceedings

  • The company is involved in various lawsuits including commercial, tort, intellectual property, tax, customer, employment, wage and hour, data privacy, securities, and anti-corruption claims, including purported class action lawsuits. Management believes these proceedings will not materially affect financial results.

Related Party Transactions

  • An Amended and Restated Master Aircraft Time Sharing Agreement is in place with Daniel Heaf (CEO), allowing for personal use of the company aircraft under specific terms and conditions, with costs imputed as income or paid by the lessee.

Stakeholder Impact

  • Shareholders: The mixed results (sales decline, profit increase due to one-time gain) may lead to varied investor reactions. The ongoing transformation strategy and future outlook will be key.
  • Employees: The 'Consumer First Formula' aims to revitalize the brand, potentially leading to new opportunities. The company's stock ownership guidelines apply to participants in equity award plans.
  • Creditors: The company's debt levels remain significant, but its liquidity and borrowing capacity appear sufficient for the near term. The repurchase of 2027 Notes reduces outstanding debt.
  • Suppliers: The company implemented a supply chain finance program, allowing suppliers early payment options at a discount, facilitated by a third-party financial institution. The company's payment obligations are not impacted.

Next Steps

  • Continue to execute the 'Consumer First Formula' transformation plan.
  • Monitor macroeconomic factors and their impact on consumer demand and costs.
  • Invest in capital expenditures focused on high return real estate, Consumer First Formula initiatives, and logistics.
  • Manage liquidity and debt levels, with potential for future debt or share repurchases.
  • Prepare for the second quarter 2026 ordinary dividend payment.

Key Dates

DateDescription
2024-01-31End of fiscal year 2024
2025-01-31End of fiscal year 2025
2025-02-01Beginning of fiscal year 2026
2025-02-27Cancellation of remaining authorization under the January 2024 Share Repurchase Program.
2025-05-03End of the first quarter of fiscal year 2025.
2026-01-31End of fiscal year 2026
2026-02-01Beginning of fiscal year 2027
2026-02-27Implementation of a supply chain finance (SCF) program.
2026-04-29Effective date of the Amended and Restated Master Aircraft Time Sharing Agreement.
2026-05-02End of the first quarter of fiscal year 2026.
2026-05-27Date of the report filing.
2026-06-05Record date for the second quarter 2026 ordinary dividend.
2026-06-19Payment date for the second quarter 2026 ordinary dividend.
2027-01-31Fiscal year end for the purpose of the Performance Share Unit award.
2027-07-01Effective date for Accounting Standards Update (ASU) 2024-03.
2029-01-27End of the Performance Period for Performance Share Units.
2030-05Expiration date of the Asset-backed Revolving Credit Facility.
2033-03Maturity date of the 6.950% Fixed Interest Rate Debentures.
2035-11Maturity date of the 6.875% Fixed Interest Rate Notes.
2036-07Maturity date of the 6.750% Fixed Interest Rate Notes.
2037-07Maturity date of the 7.600% Fixed Interest Rate Notes.

Recommendation

hold

The company's Q1 2026 results present a mixed picture. While net sales declined, operating income saw a significant boost from a one-time litigation settlement, masking underlying operational pressures like reduced gross margins. The ongoing 'Consumer First Formula' transformation is a positive long-term initiative, but its impact is yet to be fully realized. Given the sales decline and the reliance on a one-time gain for profit improvement, a 'hold' recommendation is appropriate pending clearer signs of sustained operational improvement and sales growth.

Keywords

Bath & Body Works, 10-Q, Quarterly Report, Net Sales, Operating Income, Gross Profit, Financial Statements, Consumer First Formula, Litigation Settlement, Debt Repurchase

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.